{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:57:26Z","timestamp":1779217046692,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"DOI":"10.7759\/cureus.106157","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T23:38:38Z","timestamp":1774913918000},"source":"Crossref","is-referenced-by-count":1,"title":["Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome Associated With Relugolix Therapy for Giant Uterine Fibroids and Anemia: A Case Report"],"prefix":"10.7759","author":[{"given":"Moe","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Kamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.49.4.1174","article-title":"Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction","volume":"49","author":"Ito Y","year":"1997","unstructured":"Ito Y, Niwa H, Iida T, Nagamatsu M, Yasuda T, Yanagi T, Sobue G. Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology. 1997, 49:1174-5. 10.1212\/wnl.49.4.1174","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer M","year":"2017","unstructured":"Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017, 264:1608-16. 10.1007\/s00415-016-8377-8","journal-title":"J Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2114482","article-title":"Posterior reversible encephalopathy syndrome","volume":"388","author":"Geocadin RG","year":"2023","unstructured":"Geocadin RG. Posterior reversible encephalopathy syndrome. N Engl J Med. 2023, 388:2171-8. 10.1056\/NEJMra2114482","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106472","article-title":"PRES and RCVS: Two distinct entities or a spectrum of the same disease?","volume":"31","author":"Jeanneret V","year":"2022","unstructured":"Jeanneret V, Jillella DV, Rangaraju S, et al.. PRES and RCVS: Two distinct entities or a spectrum of the same disease?. J Stroke Cerebrovasc Dis. 2022, 31:106472. 10.1016\/j.jstrokecerebrovasdis.2022.106472","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2019.62.1.69","article-title":"Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: A case report","volume":"62","author":"Lee M","year":"2019","unstructured":"Lee M, Kim TH, Kim SJ, Jee BC. Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: A case report. Obstet Gynecol Sci. 2019, 62:69-72. 10.5468\/ogs.2019.62.1.69","journal-title":"Obstet Gynecol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.xfre.2023.01.008","article-title":"Clinical applications of gonadotropin-releasing hormone analogues: A broad impact on reproductive medicine","volume":"4","author":"Saleh FL","year":"2023","unstructured":"Saleh FL, Taylor HS. Clinical applications of gonadotropin-releasing hormone analogues: A broad impact on reproductive medicine. F S Rep. 2023, 4:83-7. 10.1016\/j.xfre.2023.01.008","journal-title":"F S Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.15406\/ogij.2022.13.00654","article-title":"Gynecological uses of GnRH antagonists: Review article","volume":"13","author":"Mart\u00ednez-N\u00fa\u00f1ez EN","year":"2022","unstructured":"Mart\u00ednez-N\u00fa\u00f1ez EN, Carvallo-Ruiz DE, N\u00fa\u00f1ez-Troconis J. Gynecological uses of GnRH antagonists: Review article. Obstet Gynecol Int. 2022, 13:226-38. 10.15406\/ogij.2022.13.00654","journal-title":"Obstet Gynecol Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70135-7","article-title":"Reversible cerebral vasoconstriction syndrome","volume":"11","author":"Ducros A","year":"2012","unstructured":"Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012, 11:906-17. 10.1016\/S1474-4422(12)70135-7","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.70497","article-title":"Medical treatment of fibroids: FIGO best practice guidance","volume":"171","author":"Diaz I","year":"2025","unstructured":"Diaz I, Lumsden MA, Zeppernick M. Medical treatment of fibroids: FIGO best practice guidance. Int J Gynaecol Obstet. 2025, 171:507-12. 10.1002\/ijgo.70497","journal-title":"Int J Gynaecol Obstet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey J","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, et al.. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996, 334:494-500. 10.1056\/NEJM199602223340803","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: Clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate JE","year":"2015","unstructured":"Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: Clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015, 14:914-25. 10.1016\/s1474-4422(15)00111-8","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.53260\/grem.22302037","article-title":"Association of posterior reversible encephalopathy syndrome with gonadotropin-releasing hormone antagonist and iron therapy for anemia and uterine myoma","volume":"3","author":"Hanawa S","year":"2022","unstructured":"Hanawa S, Sanada M, Sato S, Obata S. Association of posterior reversible encephalopathy syndrome with gonadotropin-releasing hormone antagonist and iron therapy for anemia and uterine myoma. Gynecol Reprod Endocrinol Metab. 2022, 3:103-6. 10.53260\/grem.22302037","journal-title":"Gynecol Reprod Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2019.105562","article-title":"Leuprolide acetate pseudomenopause therapy as a cause of reversible cerebral vasoconstriction syndrome","volume":"187","author":"Yamada H","year":"2019","unstructured":"Yamada H, Kikuchi R, Nakamura A, Miyazaki H. Leuprolide acetate pseudomenopause therapy as a cause of reversible cerebral vasoconstriction syndrome. Clin Neurol Neurosurg. 2019, 187:105562. 10.1016\/j.clineuro.2019.105562","journal-title":"Clin Neurol Neurosurg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1051228404273820","article-title":"Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome","volume":"15","author":"Doss-Esper CE","year":"2005","unstructured":"Doss-Esper CE, Singhal AB, Smith MS, Henderson GV. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome. J Neuroimaging. 2005, 15:188-92. 10.1177\/1051228404273820","journal-title":"J Neuroimaging"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.52.147","article-title":"[A case of posterior reversible encephalopathy syndrome occurring after anemia correction]","volume":"52","author":"Matsushima M","year":"2012","unstructured":"Matsushima M, Takahashi I, Houzen H. [A case of posterior reversible encephalopathy syndrome occurring after anemia correction]. Rinsho Shinkeigaku. 2012, 52:147-51. 10.5692\/clinicalneurol.52.147","journal-title":"Rinsho Shinkeigaku"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1194-1","article-title":"Posterior reversible encephalopathy syndrome with extensive cytotoxic edema after blood transfusion: A case report and literature review","volume":"18","author":"Nakamura Y","year":"2018","unstructured":"Nakamura Y, Sugino M, Tsukahara A, Nakazawa H, Yamamoto N, Arawaka S. Posterior reversible encephalopathy syndrome with extensive cytotoxic edema after blood transfusion: A case report and literature review. BMC Neurol. 2018, 18:190. 10.1186\/s12883-018-1194-1","journal-title":"BMC Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.5250","article-title":"Reversible posterior leukoencephalopathy syndrome associated with treatment for acute exacerbation of ulcerative colitis","volume":"55","author":"Kikuchi S","year":"2016","unstructured":"Kikuchi S, Orii F, Maemoto A, Ashida T. Reversible posterior leukoencephalopathy syndrome associated with treatment for acute exacerbation of ulcerative colitis. Intern Med. 2016, 55:473-7. 10.2169\/internalmedicine.55.5250","journal-title":"Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02509-w","article-title":"Reversible cerebral vasoconstriction syndrome with cardiac involvement during treatment for iron deficiency anemia: Case report","volume":"21","author":"Oguchi K","year":"2021","unstructured":"Oguchi K, Fukushima K, Nakamura A, Takei YI. Reversible cerebral vasoconstriction syndrome with cardiac involvement during treatment for iron deficiency anemia: Case report. BMC Neurol. 2021, 21:479. 10.1186\/s12883-021-02509-w","journal-title":"BMC Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0929","article-title":"Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema","volume":"29","author":"Bartynski WS","year":"2008","unstructured":"Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008, 29:1043-9. 10.3174\/ajnr.A0929","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01541.x","article-title":"Bath-related thunderclap headache: A study of 21 consecutive patients","volume":"28","author":"Wang SJ","year":"2008","unstructured":"Wang SJ, Fuh JL, Wu ZA, Chen SP, Lirng JF. Bath-related thunderclap headache: A study of 21 consecutive patients. Cephalalgia. 2008, 28:524-30. 10.1111\/j.1468-2982.2008.01541.x","journal-title":"Cephalalgia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/448101-posterior-reversible-encephalopathy-syndrome-and-reversible-cerebral-vasoconstriction-syndrome-associated-with-relugolix-therapy-for-giant-uterine-fibroids-and-anemia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T23:38:39Z","timestamp":1774913919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/448101-posterior-reversible-encephalopathy-syndrome-and-reversible-cerebral-vasoconstriction-syndrome-associated-with-relugolix-therapy-for-giant-uterine-fibroids-and-anemia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.106157","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}